[HTML][HTML] The extracellular matrix–immune microenvironment crosstalk in cancer therapy: challenges and opportunities

L Closset, O Gultekin, S Salehi, D Sarhan, K Lehti… - Matrix Biology, 2023 - Elsevier
Targeting the tumour immune microenvironment (TIME) by cancer immunotherapy has led to
improved patient outcomes. However, response to these treatments is heterogeneous and …

The in vitro effects of Romina strawberry extract on 3D uterine leiomyosarcoma cells

S Greco, P Pellegrino, F Giampieri, F Capocasa… - Nutrients, 2023 - mdpi.com
Leiomyosarcoma is an aggressive soft tissue sarcoma derived from the smooth muscle cells
of the uterus. We tested the effect of Romina strawberry extract treatment on three …

Deep multi-omics integration approach reveals new molecular features of uterine leiomyosarcoma

RM Falcao, JES de Souza, J Gonzalez-Molina… - … et Biophysica Acta (BBA …, 2025 - Elsevier
Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer representing
approximately 25% of all uterine malignancies. The molecular heterogeneity and …

A Deep Multi-Omics Integration Approach Reveals New Molecular Features of Uterine Leiomyosarcoma

T Petta, RM Falcao, J de Souza, J Gonzalez-Molina… - 2024 - researchsquare.com
Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer representing
approximately 2-5% of all uterine malignancies. The molecular heterogeneity and …